Who We Are

Delivering on our promise for patients

Founded in 1999 in Copenhagen, Denmark, we are a dual-listed, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

We are led by an experienced international management team. Our proprietary product pipeline and next-generation antibody technologies are the result of our strong company culture and a deep passion for innovation. We are inspired by nature and the power of the immune system to transform cancer treatment.


Office Locations

We are a leading international biotech with a global footprint

Built on a foundation of science, innovation and drug discovery and development, we have offices and research centers where we collaborate to transform the way cancer is treated.

We employ more than 1,500 people globally, including at our headquarters in Denmark and core facilities in the Netherlands and the United States. In addition, we have a regional office in Japan.

Genmab A/S

Kalvebod Brygge 43
1560 Copenhagen V

Phone +45 7020 2728

CVR no. 2102 3884
LEI Code 529900MTJPDPE4MHJ122

Genmab B.V.

Visiting Address
Uppsalalaan 15
3584 CT Utrecht
The Netherlands

Postal Address
P.O. Box 85199
3508 AD Utrecht
The Netherlands

Phone +31 30 2 123 123

CVR Utrecht 30169902
VAT no. NL8095.75.000.B.01

Genmab US, Inc.

777 Scudders Mill Road
Plainsboro, NJ 08536

Phone +1 609 430 2481

Genmab K.K.

35F, Midtown Tower
9-7-1 Akasaka, Minato-ku
Tokyo 107-6235


Chamber of Commerce no.: 0104-01-14036

Contact us

Have a general inquiry?

Contact us for medical information and queries about a specific compound or program or how to participate in a clinical trial.

Rest assured, we will handle your personal data in accordance with our Privacy Policy.

Reporting Concerns

Our value of integrity and doing the right thing means that there may be times we need to speak up about behavior that is suspected may violate our policies, standards or even the law. If you suspect or observe such behavior, we ask our people to raise such concerns through any of the channels available. Genmab also encourages external partners, vendors and stakeholders to speak up and raise such concerns as they may relate to our business.

  • Join our mission

    Be a part of our team and help transform the future of cancer treatment

    Learn more

  • Putting our expertise to work

    See how we put our in-depth knowledge of antibody biology into action

    Learn about our science

  • News, events and more

    Get the latest stock information and news about Genmab

    Learn more

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.